CDH1 and cancer: Pathologically, inactivation or absence of CDH1 expression can decrease intercellular junctions and thus promote cancer invasion and metastasis, as seen in diffuse gastric cancer (Melo et al., 2017) and lobular breast cancer (McVeigh et al., 2014).